Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

At NECCI PR Roundtable 2023, Nkechi Ali-Balogun links fight against illicit trade to effective communication


News provided by

NECCI PR Roundtable

03 Nov, 2023, 18:22 GMT

Share this article

Share toX

Share this article

Share toX

LAGOS, Nigeria, Nov. 3, 2023 /PRNewswire/ -- The convener NECCI PR Roundtable 2023, Nkechi Ali-Balogun has identified communication as a strategic tool in the battle against illicit trade.


In her welcome address at the 23rd edition, held at the prestigious Eko Hotel and Suites, Lagos recently, the veteran PR practitioner observed the pharmaceutical industry has witnessed remarkable advancements, boasting the potential to transform lives.

Continue Reading
This image opens in the lightbox
L-R, Dr. Yele Okeremi, CEO, Precise Financial Systems, Dr Segun Oke, Zonal Commander, NDLEA, Representing the Chairman NDLEA, Prof. ‬Mbang Femi-Oyewo, Professor of Pharmaceutics and Pharmaceutical Technology, Senator Daisy Danjuma, Chairman, May & Baker, Nkechi Ali-Balogun, Convener, NECCI PR Roundtable, Professor Christiana Adeyeye, DG NAFDAC, Pharm. Biodun Soremekun, Chairman Biofem Group, Chief Adebayo Ojo, MD, Caritas, Mr. Mahmood Ali-Balogun, MD, BrickHouse Media

Regrettably, she added the dark shadow of illicit trade threatens the very core of the industry's noble mission, jeopardizing public health and eroding the trust fundamental to the patient industry relationship.

Specifically, Nkechi noted communication, as a powerful tool, plays a major role in the battle against illicit trade.

To her, communication plays a vital role in sharing best practices, raising awareness and fostering collaboration among stakeholders, strengthening regulatory frameworks, and providing transparency within the supply chain to track products from manufacturer to patients.

Fielding questions from journalists, she disclosed, "right from the onset, the aim of the PR Roundtable is to bring to the fore topical issues that needed communication. Information is power and without information, we can't have knowledge and without knowledge, we can't have understanding. The PR Roundtable interrogates topical issues, importance of communication and how it impacts on relationships, businesses and lifestyle.

On how she has weathered the storm in the last twenty-three years, she responded: "It's all about passion and patriotism. Irrespective of what is happening, I love Nigeria. I know we have so much to celebrate and talk about in this country."

In the area of challenges, she identified funding, adding, "we don't mind partnership with the government."

Speaking on the theme of the event: "Fighting the Scourge of Illicit Trade in The Pharma Industry: The Role of Communication," she stated: "I have seen people die taking fake drugs, I have seen people turning nurses overnight and patients are taken to their homes. It is on the increase. The question is, how long are we going to continue; how long will the village man or market woman buy drugs without knowing whether it is fake or not; how do they identify fake drugs or the implication of taking fake drugs?

Commenting on the impact of the programme, she recalled, "I remember we were the first to hold a programme on how the nation can benefit from the Blue Economy. Today, everybody is talking about the Blue Economy."

In her keynote address, Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Moji Adeyeye, noted the proliferation of sub-standard and falsified medicines pose danger to public health and economic growth.

Specifically, she said illicit sales and distribution of sub-standard and falsified medicines were threatening the attainment of United Nations Sustainable Development Goals and leading to global assault on public health globally.

This menace, she noted portends grave financial losses, possible divestment and close of shop for the pharmaceutical industry.

Adeyeye, however, said no single agency could undertake the battle alone, adding that the approach must be multi-faceted.

Saying concerted efforts were needed, she further identified gaps as uncoordinated drug distribution and supply chain system; drug hawking and proliferation of street/ open drug markets; increasing use of postal/ courier services for dispatch of small parcels of sub-standard and falsified medicines; availability of advanced technologies; reduced risks of prosecution; non-deterrent laws and weak penalties; proliferation of rogue online pharmacists/ unregulated sales of medicines online; ignorance, poverty and high cost of living; scarcity of medicines and abuse of free trade zones and lawful trade facilitation mechanisms.

On what NAFDAC is doing to bridge the gaps, she listed attainment of ISO9001:2015 certification and WHO Maturity Level 3, which implies that NAFDAC has reached the level of regulatory system operating as a stable, well-functioning and integrated system for the regulation of medicines and imported vaccines in an efficient, effective and transparent manner, to achieve Universal Health Coverage by access to safe, effective, quality and affordable essential medicine and vaccines for all Nigerians.

Chairman NECCI PR Roundtable 2023, Senator Daisy Danjuma noted there is need to commend Nkechi for sustaining the programme for twenty three years. She assured: "We'll try our best to support the programme."

She also expressed happiness with presence of the young undergraduates at the event, adding they need to be properly equipped to confront future challenges.

For the first time, the NECCI PR Roundtable Hall of Fame was instituted to reognise and celebrate corporate organisations and individuals for their outstanding contributions to the growth of the PR industry.

The awardees include: Stanbic-IBTC, First Bank Nigeria PLC, The Nigerian Maritime Administration and Safety Agency, (NIMASA), Zenith Bank, Senator Daisy Danjuma, Dr. Akinwunmi Adeshina and Dr. Bennedict Oramah as Great PR ambassador of the continent.

Moderated by the founder Light House Network, Nkiru Olumide Ojo, other speakers at the event include, Comptroller General Nigeria Customs Service Adewole Adeniyi; CEO National Drug Law Enforcement Agency (NDLEA) Mohammad Buba Marwa; Provost College of Pharmacy Afe Babalola University Ado-Ekiti Mbang Femi Oyewole; CEO Proshare Nigeria Olufemi Awoyemi; CEO Corporate Advisor Bolarinwa Onoolapo, Founder Biofem Group Olufemi Soremekun and lecturer St. Augustine University, Tanzania Dr. David Mrisho.

Photo: https://mma.prnewswire.com/media/2266002/Illicit_Trade_NECCI_PR_Roundtable.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.